Depression in Chronic Airways Diseases

NCT03180164 | Unknown

• 1 other identifier: CLD
• Study Type: interventional
• Target: 1
• Locations: 0 countries
• Sites: N/A

Brief Summary

Chronic airways diseases involve alterations in the person's social roles, relationships and self-perception so demands continual psychological adjustment . Also Kunik studied patients with chronic breathing disorders for depression and anxiety and found that 65% of patients were positive for depression and anxiety. Shackell found that patients' anxiety and fears of breathlessness and dying extended into the night and were aggravated by feelings of isolation and frustration. One patient reported that they often thought 'am I going to see the next morning?'

Conditions

Chronic Lung Disease

Outcome Measures

Primary Outcomes (1)

• compare anxiety and depression in different forms of chronic lung diseases

  by hospital anxiety and depression scale

  10 minutes

Study Arms (1)

chronic lung diseases

OTHER

bronchiectasis , bronchial asthma and chronic obstructive pulmonary disease assess anxiety and depression by hospital anxiety and depression scale

Other: hospital anxiety and depression scale

Interventions

hospital anxiety and depression scale OTHER

self-assessment scale has been developed and found to be a reliable instrument for detecting states of depression and anxiety in the setting of an hospital medical outpatient clinic

chronic lung diseases

Eligibility Criteria

• Age: 18 Years - 60 Years
• Sex: all
• Healthy Volunteers: No
• Age Groups: Adult (18-64)

You may qualify if:

• Chronic airways diseases as chronic obstructive pulmonary disease, bronchial asthma, bronchiectasis

You may not qualify if:

• Diabetes Mellitus and Hypertension.
• Cardiac diseases.
• Chronic renal and liver diseases.

Sponsors & Collaborators

• Assiut University: lead

MeSH Terms

Interventions

4-amino-4'-hydroxylaminodiphenylsulfone

Study Officials

• Reham Mohamed El-Morshedy

  Assiut University

  STUDY CHAIR

Central Study Contacts

Maha Ahmed El-Kholy

CONTACT

00201096956205; maha_elkholy@gmail.com

Samiaa Hamdy Sadek

CONTACT

00201006769597; samiaa_sadek@yahoo.com

Study Design

• Study Type: interventional
• Phase: not applicable
• Allocation: NA
• Masking: NONE
• Purpose: SCREENING
• Intervention Model: SINGLE GROUP
• Sponsor Type: OTHER
• Responsible Party: PRINCIPAL INVESTIGATOR
• PI Title: principle investigator

Study Record Dates

• First Submitted: June 6, 2017
• First Posted: June 8, 2017
• Study Start: October 1, 2018
• Primary Completion: October 1, 2019
• Study Completion: October 1, 2019
• Last Updated: January 9, 2018

Record last verified: 2018-01

Data Sharing

• IPD Sharing: Will not share